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most prescribing is empirical with broad-spectrum agents being used
increasingly. This creates two important problems. First, it encour-
ages resistance to a wide range of agents and decreases options for pre-
scribing in the future. Secondly, it eradicates more of the normal
protective flora, rendering patients more susceptible to super-infec-
tion by resistant pathogenic strains. Recent studies have provided evi-
dence of an increase in the levels of antibiotic resistance among
organisms isolated from the oral cavity.5–9 Furthermore, oral strepto-
cocci, such as S. oralis, have been implicated as a source of the peni-
cillin resistance trait in S. pneumonia.10
Since antimicrobial mis-use and over-use is a major risk factor
for the development of resistance,11 improved prescribing must be
a cornerstone to tackling resistant organisms. Crucial to this
process is involvement of the clinical microbiology laboratory,
which not only provides the data on which therapeutic decisions
that discourage the development of resistance can be made, but
also provides the expertise needed for resistance surveillance. 
Further, this information is useful in the development of local poli-
cies and guidelines on antibiotic prescribing, the routine dissemi-
nation of which have an important educational value and
beneficially influence prescribing habits.12
Encouraging GDPs to prescribe rationally is a highly desirable objec-
tive. However, the role of the diagnostic microbiology laboratory in its
achievement has usually been by default, generally being consulted for
common infections only when empirical therapy has failed. In an
attempt to encourage GDPs to use the diagnostic oral microbiology lab-
oratory at the Glasgow Dental Hospital and School as an aid in their
decision-making process for antibiotic treatment, this study took a con-
sultative approach to determine their opinions on the current service.
Information was also sought regarding potential barriers to its use. 
Methods and materials
All GDPs (1,864), in every health board within Scotland have access
to the facilities provided by the Glasgow Dental Hospital. However,
in reality, GDPs practising within the Western and Central health
boards are more likely to use it. The extent of the problem was
analysed by examining laboratory records from 1993 to 1997. The
total number of specimens received from GDPs ranged from 45 to
17 per year, with a 40% reduction being observed during the 5-year
period. This suggested that prescribing in general dental practice
was empirical. Examining samples collected from dento-alveolar
abscesses provided an indication of the quality of the specimens
submitted. Of the 40 specimens received, seven (18%) were consid-
ered an appropriate specimen, that is, an aspirate of pus. The
remainder comprised pus swabs or paper point specimens.
Following piloting, a questionnaire together with a person-
alised letter and a pre-paid reply envelope were mailed to all den-
tists (797) practising within the four health boards surrounding
the Glasgow Dental Hospital, namely Argyll and Clyde, Ayrshire
and Arran, Lanarkshire and Greater Glasgow Health Board. Non-
Objective To identify barriers on the use of diagnostic
microbiology facilities in general dental practice.
Design A cross-sectional survey using a postal questionnaire.
Setting Primary/secondary care interface between the
diagnostic oral microbiology laboratory, University of Glasgow
Dental Hospital and School, Glasgow and dental practitioners
within the surrounding health boards, 1998.
Subjects All GDPs (797) within Argyll and Clyde, Ayrshire and
Arran, Lanarkshire and Greater Glasgow Health Boards.
Main outcome measures The responses were expressed as
both absolute and relative frequencies.
Results Responses were received from 430 (55%). The most
frequent reason for failure to use the service was lack of
information, with more than half of the respondents claiming to
be unaware of the facility. Lack of request forms and sampling
equipment were also viewed as barriers to using the service. 
Conclusions The laboratory is failing to successfully
communicate its role in addressing the growing burden of
antibiotic resistance in the community and must be more
proactive  in encouraging appropriate use and increasing
accessibility of the service to GDPs. 
In 1997, the Select Committee on Science and Technology of the
House of Lords carried out a public inquiry into the increasingly
pressing problem of the development of antibiotic resistance.
Among others, the report recommended the more prudent use of
antibiotics in human medicine supported by a number of surveil-
lance and education measures.1
Within the UK, prescriptions of antibiotics by the dental profes-
sion cost the General Dental Services at least £4.5 million per year.2
On top of such visible sums are the potential hidden expenses
caused by the treatment of antibiotic resistant infections. The con-
tribution of the dental profession to the worldwide problem of
antibiotic resistance remains as yet unknown.  
The prescription of antibiotics is an important adjunct to the prac-
tice of dentistry, playing an important role both in the management
of suppurative infections such as dento-alveolar abscesses and acute
periocoronitis, and in prophylactic cover of medically-compromised
patients. As in general medicine, this privilege is routinely abused and
it has been shown that prescribing is generally suboptimal with wide
variations both in the types and doses of antibiotics.3,4 Furthermore,
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respondents were sent a further explanatory letter three weeks
after the initial mailing.
The questionnaire contained 18 items. A combination of close-
ended questions (both ordered and unordered) and partially closed
questions were posed. Care was taken with the order of the ques-
tions, not to make the questions repetitive, and to make the ques-
tionnaire aesthetically pleasing and easy to complete. The overall
design of the questionnaire aimed to encourage the response
through three mechanisms. First by using a consultative approach,
giving the true impression that the views and opinions of the den-
tists were appreciated. Secondly, by ensuring that the physical and
mental effort required to complete the questionnaire was minimal
and thirdly, the researchers sought to establish trust by identifying
with a known organisation that has legitimacy.
The questionnaire was developed in three parts. Part A collected
information to explore how the demographics of the responding
GDPs who used the service differed from those who did not. Data
on gender, practice distance from Glasgow Dental Hospital, practice
size and practice speciality were collected. Part B was designed to
assess the attitudes of the GDPs who had used the service previously.
Views were sought on the request forms, the transportation and
processing of specimens, reporting procedures, microbiological
advice provided, and the quality of the service as a whole. Informa-
tion was also obtained on the frequency of use of the service. The
final section sought opinions on a number of potential barriers to
the service. GDPs were also asked about their views on a number of
potential services being considered by the laboratory to improve the
use of the facility. Information was also collected on the attitudes of
the GDPs toward  microbiological sampling for a number of clinical
conditions and for monitoring antibiotic sensitivity levels. The final
questions in this section clarified whether GDPs were using alterna-
tive facilities and whether they were aware that a fee was payable by
the NHS for each sample submitted for microbiological examination.
Non-bias response was assessed in terms of the variables that were
known for the entire sample being studied, namely distance from Glas-
gow Dental Hospital as defined by the health board and practice size. As
non-respondents are considered to be more like late respondents than
early respondents,13 the representativeness of the respondents was
determined by comparing early respondents (those received following
the initial mailshot) with late respondents (those received after the
explanatory letter), as well as respondents with non-respondents.
Data analysis was carried out using Minitab. Frequencies were
used to examine the distribution of responses for all the variables
and to describe sample demographics. The association between
variables was examined by cross-tabulations and the statistical sig-
nificance of such relationships examined by chi-squared analysis.
Results
Twenty of the 797 questionnaires were returned as undelivered and it
was assumed that 777 questionnaires had reached their destination; 430
completed questionnaires were returned representing a 55% response
rate discounting undelivered questionnaires.
There was no evidence of non-response bias when comparing
early respondents with late respondents. Comparison of all respon-
dents with non-respondents also indicated no difference with
regard to the distance from the laboratory. However, there was a sig-
nificant difference between practice size and whether or not the
GDPs responded. In particular, the number of GDPs practising sin-
gle-handed was under-represented.
Of the responding GDPs, just under half (48%) were aware of the
diagnostic microbiology service. However, only 68 (15%) of the
respondents had previously used it. There were no significant dif-
ferences between those dentists who had used the service and those
who had not with regard to gender, practice distance from the labo-
ratory, practice size and speciality. An alternative laboratory had
been consulted by 33 (7.7%) of the responding GDPs. Although the
use of a local hospital was more common by GDPs practising fur-
ther away, the difference was not statistically significant.
Respondents who had previously used the microbiology service were
asked to express their degree of satisfaction with the service by choosing
one of the following options: excellent, good, average or poor. Opinions
were sought on the respondent’s experience with the request forms, the
transportation procedures, turnaround time, the format and delivery of
the report, microbiological advice provided and the quality of the ser-
vice as a whole. The data indicated a high degree of satisfaction with the
service although around a quarter failed to comment on each issue. This
may be indicative of the practitioner being unable to recall the details of
any interaction in the past.  
From a list provided, respondents were asked to identify the bar-
riers to their use of the service. This included an ‘any other’ option
that invited the dentist to comment specifically on any obstacle that
they felt existed which had not been already covered. Of those pro-
posed, lack of information about the service was considered the
biggest problem by 300 (70%). This was followed by lack of sam-
pling equipment (181; 42.1%), lack of request forms (149; 34.6%)
and issues concerning transport (105; 24.4%). Time taken to collect
the samples and the time taken to receive the results were seen
equally as a barrier by 37 (8.6%). Lack of address labels was consid-
ered a barrier by 94 (21.9%) and cost by 22 (5.1%). Fifteen respon-
dents felt there were barriers other than those listed including:
• Feeling that microbiological sampling was not necessary
• Distance.
Cross-tabulation followed by chi-squared analysis showed a statis-
tically-significant relationship between not using the service and lack
of information, sampling equipment and request forms (Table 1).
Of the proposed solutions to these barriers, 365 (84.9%) of the
respondents felt an information booklet describing the service
would be of use. This was closely followed by provision of sampling
packs containing the necessary equipment for specimen collection
(81.6%). Information on taking samples and the transport of speci-
mens was also considered appropriate by a similar number (67.7%).
The attitudes toward microbial sampling in general practice indi-
cated that with the exception of determining antibiotic sensitivities,
microbiological sampling was not considered important for moni-
toring endodontic treatment, periodontal treatment, implants,
dental abscesses, denture stomatitis or pericoronitis. There was,
however, a wide variation in opinions expressed.
Discussion
In view of the changing epidemiology of antibiotic resistance in the
community, we felt it prudent to examine the role of a specialist oral
microbiology diagnostic service available to GDPs and the barriers to
the use of such a service. We were encouraged to find that a large pro-
portion of GDPs were supportive of the role of the laboratory but
concerned to find that the majority were unaware of it. One could
argue that the high percentage of non-respondents suggests an even
greater lack of interest in the service than indicated here. This argu-
ment hinges on the effect of non-response bias, which does increase
Table 1 Barriers to the use of the oral microbiology service by
previous users and non-users
Barrier Previously used the microbiology service P – value 
Yes (N = 63) No (N = 367)
Lack of information 12 288 < 0.001
Time collecting samples 6 31 0.78
Time taken to get result 8 29 0.21
Lack of request forms 14 135 0.025
Lack of address labels 16 78 0.46
Lack of equipment 19 162 0.037
Cost 5 17 0.27
Problems with transportation 13 92 0.45
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when the response rate is low and when non-respondents differ from
respondents in the parameters of interest.13 There was, however, no
evidence of non-response bias with the exception that the opinions of
GDPs practising alone may be under-represented. Thus, although the
response rate of the recipients was in the suspect category as specified
in the BDJ,14 it was felt that the results provided a good indication of
the potential barriers which prevent the use of the diagnostic service
for bacteriological identification and antibiotic sensitivity testing.
Lack of time, both for collecting samples and obtaining the labora-
tory results was hypothesised initially as being an important variable
preventing the use of the diagnostic service to aid rational prescribing.
This was not, however, shown to be significantly associated with the lack
of use and neither was it considered an impediment by the respondents.
Issues regarding time have encouraged the development of ‘rapid tests’.1
Yet even with a faster turnaround time, the results are not available at
the time antimicrobials are prescribed. It may be that the respondents
felt that improving turnaround time would not affect how they pre-
scribed in practice. This is where knowledge of local antibiotic sensitiv-
ity profiles can aid the initial decision of which antibiotic to prescribe. 
Lack of time for collecting a specimen is more likely to be an issue
with dentists practising single-handed and, as mentioned, this
group of practitioners was under-represented. Therefore, the effect
of this variable on the use of the diagnostic facility remains unan-
swered from this survey.
The effect of age was not investigated in this study as demographic
information available on GDPs who had used the service previously
indicated that the pressures of time and distance from the service
may overrule any effect of age. However, age (or year of qualifica-
tion), may be important and should be considered in future studies.
The majority of respondents considered lack of information about
the service as the biggest barrier to its use. This study identified that a
major need of the GDPs was access to more comprehensive informa-
tion on the service provided. The provision of a laboratory handbook
containing information on the range of tests available, on specimen
collection procedures and on recommended transportation require-
ments, is an obvious way of meeting this need and was considered to
be constructive by the majority of practitioners who responded to the
survey. Such information should be readily available from all labora-
tories with clinical pathology accreditation (CPA) status. However, it
seems unlikely that provision of this information alone would change
current behaviour and it must be followed through with continuing
professional education and development. GDPs receive a fee of £7.90
from the NHS for microbiological sampling but few appear to know
about it and those that do feel it is somewhat inadequate. 
It was reassuring that more than three-quarters of the respon-
dents appreciated the need for development of antibiotic guidelines
and the provision of regular updates on local antibiotic sensitivity
profiles. This indicates that GDPs are amenable to advice on antimi-
crobial management of their patients and that rational prescribing
could be achieved in the primary dental care setting. It was also reas-
suring that GDPs were aware of the importance of microbial sam-
pling for this purpose, though only 15% claimed to have previously
obtained a specimen and sent it to the laboratory for bacteriological
identification and sensitivity testing.
Dentists appear to be unaware of how or where the information on
local sensitivities, used for the development of guidelines and policies
is obtained. This is reflected by the fact that most considered microbi-
ological sampling to be of only average importance in endodontic and
periodontal treatment, for monitoring implant success, and for the
management of dental abscesses, denture stomatitis and pericoroni-
tis. All are common scenarios encountered routinely in general prac-
tice resulting in (often inappropriate) prescription of antimicrobial
agents. There is a gap in the knowledge of dentists regarding the
importance to the clinical laboratory of samples collected in general
practice for microbiological analysis, without which surveillance of
resistance cannot be undertaken and appropriate policies developed;
this message must be communicated. However, it needs to be one that
emphasises the need for appropriate clinical specimens. Misleading
or incorrect laboratory reports invite inappropriate prescribing, par-
ticularly if contaminating commensals are reported as significant.
The only way to remove the uncertainty in prescribing is to examine
clinical material bacteriologically to identify the infecting organism and
its antibiotic sensitivity profile. However, we do not recommend that
GDPs establish antimicrobial susceptibility before every antibiotic pre-
scribed. This would at present be impracticable and financially impossi-
ble in today’s climate. The BDA advises that bacteriological sampling
should always be carried out in severe infections . Yet this survey indi-
cates that the vast majority of dentists fail to do so. Guidelines on the
appropriate use of the microbiology laboratory are therefore needed to
complement policies on preventing antimicrobial resistance.
Conclusion
The microbiology laboratory has an important role to play in moni-
toring the emergence of antibiotic resistance in oral infections and
to slow down the spread of resistant strains. Specifically, these objec-
tives can be met through active surveillance and the promotion of
rational and moderate antibiotic use. Each affects and depends on
the other and cannot be performed without the help of the GDPs in
the community setting. This survey has indicated that GDPs are
aware of the importance of microbial sampling for monitoring
resistance but their failure to do so, in this situation, resulted from a
lack of communication. Diagnostic laboratories must take a proac-
tive role in encouraging appropriate use and making their facilities
as accessible as possible to the GDPs. This will permit accurate and
rational prescribing and allow the profession to cooperate with
other health care professionals in addressing the growing burden of
antibiotic resistance in both hospitals and the community. 
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